Assessment of angiogenesis and tumor growth in conscious mice by a fluorimetric method

Microvascular Research

Volumn 59, Issue 2, 2000, Pages 278-285

  Lage, Ana Paula ^a   Andrade, Silvia P ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Angiogenesis; Conscious animals; Fluorimetric method; Tumor blood flow

Indexed keywords

DEXAMETHASONE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; FLUOROMETRY; HEMODYNAMIC MONITORING; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR BLOOD FLOW; TUMOR GROWTH;

ANIMALIA;

EID: 0034057308     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.1999.2217     Document Type: Article

References (29)

1. Andrade S. P., Hart I. R., Piper P. J. Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature. Br. J. Pharmacol. 107:1992;1092-1095.
2. Andrade S. P., Machado R. D. P., Teixeira A. S., Belo A. V., Tarso A. M., Beraldo W. T. Sponge-induced angiogenesis in mice and the pharmacological reactivity of the neovasculature quantitated by a fluorimetric method. Microvasc. Res. 54:1997;253-261.
3. Auerbach R., Auerbach W., Polakowski I. Assays for angiogenesis: A review. Pharmacol. Ther. 51:1991;1-11.
4. Ausprunk D. H., Folkman J. Migration and proliferation of endothelial cells in preformed blood vessels during tumor angiogenesis. Microvasc. Res. 14:1977;53-56.
5. Battegay E. J. Angiogenesis: Mechanistic insights, neovascular diseases and therapeutic prospects. J. Mol. Med. 73:1995;333-346.
6. Colantuoni A., Bertuglia S., Intaglietta M. Effects of anesthesia on the spontaneous activity of the microvasculature. Int. J. Microcirc. Clin. Exp. 3:1984;13-28.
7. Dvorak H. F. Tumors: Wounds that do not heal. N. Eng. J. Med. 315:1986;1656-1659.
8. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1:1995;27-31.
9. Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 267:1992;10931-10934.
10. Folkman J., Brem H. Angiogenesis and Inflammation. Gallin J. I., Goldstein I. M., Snyderman R. Inflammation: Basic Principles and Clinical Correlates. 1992;821-839 Raven Press, New York.
11. Folkman J., Ingber D. E. Angiostatic steroids. Methods of discovery and mechanism of action. Ann. Surg. 206:1987;374-382.
12. Freitas I., Baronzio G. F., Bertone V., Griffini P., Acossato P., Pontiggia P. Tumor angiogenesis: Evidence of new blood channels for plasma infiltrations. Anticancer Res. 2:1991;569-578.
13. Gasparini G. Prognostic and predictive value of intra-tumoral microvessel density in human solid tumors. Bicknell R., Lewis C. E., Ferrara N. Tumour Angiogenesis. 1997;29-44 Oxford Univ. Press, New York.
14. Hori Y., Hu D-E., Yasui K., Smither R. L., Gresham G. A., Fan T-P. D. Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in the rat sponge implants. Br. J. Pharmacol. 118:1996;1587-1591.
15. Hu D-E., Hiley C. R., Smither R. L., Gresham G. A., Fan T-P. D. Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis. Lab. Invest. 72:1995;601-610.
16. Ingber D. E., Madri J. A., Folkman J. A possible mechanism for inhibition of angiogenesis by angiostatic steroids: Induction of capillary basement membrane dissolution. Endocrinology. 119:1986;1768-1775.
17. Jain R. K., Schlenger K., Hockel M., Yuan F. Quantitative angiogenesis assays: Progress and problems. Nature Med. 3:1997;1203-1208.
18. Jain R. K. The next frontier of molecular medicine: Delivery of therapeutics. Nature Med. 4:1998;655-657.
19. Leunig M., Yuan F., Menger M. D., Boucher Y., Goetz A. E., Messmer K., Jain R. K. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res. 52:1992;6553-6560.
20. Mahadevan V., Malik S. T. A., Meager A., Fiers W., Lewis G. P., Hart I. R. Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown. Cancer Res. 50:1990;5537-5542.
21. Maragoudakis M. E., Panoutsacopoulou M., Sarmonika M. Rate of basement membrane synthesis as an index of angiogenesis. Tissue Cell. 20:1988;531-539.
22. McGrath J. C., Arribas S., Daly C. J. Fluorescent ligands for the study of receptors. Trends Pharmacol. Sci. 17:1996;393-399.
23. Passaniti A., Taylor A. M., Pili R., Guo Y., Long P. V., Haney J. A., Pauly R. R., Grant D. S., Martin D. R. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67:1992;519-528.
24. Pesenti E., Sola F., Mongelli N., Grandi M., Spreafico F. Suramin prevents neovascularisation and tumor growth through blocking of basic fibroblast growth factor activity. Br. J. Cancer. 66:1992;367-372.
25. Peterson H-I. Modification of tumour blood flow - A review. Int. J. Radiat. 60:1991;201-210.
26. Rocha e Silva M., Belo A. V., Machado R. D. P., Andrade S. P. Clotrimazole is an inhibitor of inflammatory angiogenesis and metabolic activity of sponge granuloma. Inflammation. 22:1998;643-651.
27. Thiede K., Momburg F., Zangemeister U., Schlag P., Schirrmacher V. Growth and metastasis of human tumors in nude mice following tumor-cell inoculation into a vascularized polyurethane sponge matrix. Int. J. Cancer. 42:1988;939-945.
28. Vogel A. W. Intratumoral vascular changes with increased size of a mammary adenocarcinoma: New method and results. J. Natl. Cancer Inst. 34:1965;571-578.
29. Weidner N., Folkman J. Tumoral vascularity as a prognostic factor in cancer. Import. Adv. Oncol. 11:1996;167-190.